Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaohong Sun

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 2008
Molecular determinants of species-specific activation or blockade of TRPA1 channelsJun Chen, Xu-Feng Zhang, Michael E Kort, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2010
Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMRAndrew M Petros, Jeffrey R Huth, Thorsten Oost, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Discovery of a novel small molecule binding site of human survivinMichael D Wendt, Chaohong Sun, Aaron Kunzer, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-X<sub>L</sub> InhibitorZhi-Fu Tao, Xilu Wang, Jun Chen, et al.
Journal of Medicinal Chemistry|August 20, 2004
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancerThorsten K Oost, Chaohong Sun, Robert C Armstrong, et al.
Molecular Cancer Therapeutics|February 9, 2026
Microsatellite instable cancer cells acquire on-target resistance mutations to WRN helicase inhibitorsFaith Fowler, Jessica Gajda, Amirhossein Mafi, et al.
Journal of Medicinal Chemistry|April 2, 2019
Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) StabilizerAndrew M Petros, Alla Korepanova, Clarissa G Jakob, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED bindingMichael L Curtin, Marina A Pliushchev, Huan-Qiu Li, et al.
ACS Chemical Biology|February 21, 2022
The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for ImmunotherapySven Malchow, Alla Korepanova, Sanjay C Panchal, et al.
Scientific Reports|August 26, 2022
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal siteEric R Goedken, Maria A Argiriadi, Justin D Dietrich, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 2008
Molecular determinants of species-specific activation or blockade of TRPA1 channelsJun Chen, Xu-Feng Zhang, Michael E Kort, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2010
Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMRAndrew M Petros, Jeffrey R Huth, Thorsten Oost, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Discovery of a novel small molecule binding site of human survivinMichael D Wendt, Chaohong Sun, Aaron Kunzer, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-X<sub>L</sub> InhibitorZhi-Fu Tao, Xilu Wang, Jun Chen, et al.
Journal of Medicinal Chemistry|August 20, 2004
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancerThorsten K Oost, Chaohong Sun, Robert C Armstrong, et al.
Molecular Cancer Therapeutics|February 9, 2026
Microsatellite instable cancer cells acquire on-target resistance mutations to WRN helicase inhibitorsFaith Fowler, Jessica Gajda, Amirhossein Mafi, et al.
Journal of Medicinal Chemistry|April 2, 2019
Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) StabilizerAndrew M Petros, Alla Korepanova, Clarissa G Jakob, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED bindingMichael L Curtin, Marina A Pliushchev, Huan-Qiu Li, et al.
ACS Chemical Biology|February 21, 2022
The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for ImmunotherapySven Malchow, Alla Korepanova, Sanjay C Panchal, et al.
Scientific Reports|August 26, 2022
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal siteEric R Goedken, Maria A Argiriadi, Justin D Dietrich, et al.
Pageof 6